141 related articles for article (PubMed ID: 32617582)
1. Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study.
Erickson SB; Zand L; Nasr SH; Alexander MP; Leung N; Drosou ME; Fervenza FC
Nephrol Dial Transplant; 2021 Jan; 36(1):104-110. PubMed ID: 32617582
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of DNAJB9-Positive Fibrillary Glomerulonephritis After Kidney Transplantation: A Case Series.
El Ters M; Bobart SA; Cornell LD; Leung N; Bentall A; Sethi S; Fidler M; Grande J; Hernandez LH; Cosio FG; Zand L; Amer H; Fervenza FC; Nasr SH; Alexander MP
Am J Kidney Dis; 2020 Oct; 76(4):500-510. PubMed ID: 32414663
[TBL] [Abstract][Full Text] [Related]
3. Fibrillary Glomerulonephritis: Clinicopathologic Features and Atypical Cases from a Multi-Institutional Cohort.
Andeen NK; Troxell ML; Riazy M; Avasare RS; Lapasia J; Jefferson JA; Akilesh S; Najafian B; Nicosia RF; Alpers CE; Smith KD
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1741-1750. PubMed ID: 31685544
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases.
Said SM; Rocha AB; Royal V; Valeri AM; Larsen CP; Theis JD; Vrana JA; McPhail ED; Bandi L; Safabakhsh S; Barnes C; Cornell LD; Fidler ME; Alexander MP; Leung N; Nasr SH
Am J Kidney Dis; 2021 Mar; 77(3):454-458. PubMed ID: 32711071
[TBL] [Abstract][Full Text] [Related]
5. DNAJB9 Fibrillary Glomerulonephritis With Membranous-Like Pattern: A Case-Based Literature Review.
Sabanis N; Liaveri P; Geladari V; Liapis G; Moustakas G
Cureus; 2023 Oct; 15(10):e47862. PubMed ID: 37899889
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker.
Liang S; Chen D; Liang D; Xu F; Zhang M; Yang F; Zhu X; Li P; Zeng C
J Nephrol; 2021 Jun; 34(3):883-892. PubMed ID: 32557205
[TBL] [Abstract][Full Text] [Related]
7. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
[TBL] [Abstract][Full Text] [Related]
8. IgA-dominant glomerulonephritis with DNAJB9-negative fibrillar polytypic immunoglobulin deposits in the subepithelium.
Muto R; Maeda K; Fukui S; Saito S; Kato N; Kosugi T; Shimizu A; Maruyama S
CEN Case Rep; 2023 Aug; 12(3):323-328. PubMed ID: 36576710
[TBL] [Abstract][Full Text] [Related]
9. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.
Rosenstock JL; Markowitz GS; Valeri AM; Sacchi G; Appel GB; D'Agati VD
Kidney Int; 2003 Apr; 63(4):1450-61. PubMed ID: 12631361
[TBL] [Abstract][Full Text] [Related]
10. Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9).
Klomjit N; Alexander MP; Zand L
Kidney360; 2020 Sep; 1(9):1002-1013. PubMed ID: 35369552
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of patients with coexisting DNAJB9-associated fibrillary glomerulonephritis and IgA nephropathy.
Said SM; Rocha AB; Valeri AM; Sandid M; Ray AS; Fidler ME; Alexander MP; Larsen CP; Nasr SH
Clin Kidney J; 2021 Jun; 14(6):1681-1690. PubMed ID: 34084464
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features and treatment outcomes of patients with fibrillary glomerulonephritis: A case series.
Marinaki S; Tsiakas S; Liapis G; Skalioti C; Kapsia E; Lionaki S; Boletis J
Medicine (Baltimore); 2021 May; 100(20):e26022. PubMed ID: 34011106
[TBL] [Abstract][Full Text] [Related]
13. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fervenza FC; Appel GB; Barbour SJ; Rovin BH; Lafayette RA; Aslam N; Jefferson JA; Gipson PE; Rizk DV; Sedor JR; Simon JF; McCarthy ET; Brenchley P; Sethi S; Avila-Casado C; Beanlands H; Lieske JC; Philibert D; Li T; Thomas LF; Green DF; Juncos LA; Beara-Lasic L; Blumenthal SS; Sussman AN; Erickson SB; Hladunewich M; Canetta PA; Hebert LA; Leung N; Radhakrishnan J; Reich HN; Parikh SV; Gipson DS; Lee DK; da Costa BR; Jüni P; Cattran DC;
N Engl J Med; 2019 Jul; 381(1):36-46. PubMed ID: 31269364
[TBL] [Abstract][Full Text] [Related]
14. Rituximab treatment for fibrillary glomerulonephritis.
Hogan J; Restivo M; Canetta PA; Herlitz LC; Radhakrishnan J; Appel GB; Bomback AS
Nephrol Dial Transplant; 2014 Oct; 29(10):1925-31. PubMed ID: 24867652
[TBL] [Abstract][Full Text] [Related]
15. Therapy of Rituximab in Idiopathic Membranous Nephropathy with Nephrotic Syndrome: A Systematic Review and Meta-analysis.
Zou PM; Li H; Cai JF; Chen ZJ; Li C; Li XW
Chin Med Sci J; 2018 Mar; 33(1):9-19. PubMed ID: 29620510
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients.
Nasr SH; Dasari S; Lieske JC; Benson LM; Vanderboom PM; Holtz-Heppelmann CJ; Giesen CD; Snyder MR; Erickson SB; Fervenza FC; Leung N; Kurtin PJ; Alexander MP
Kidney Int; 2019 May; 95(5):1269-1272. PubMed ID: 31010480
[TBL] [Abstract][Full Text] [Related]
17. Rituximab as a rescue therapy in patients with glomerulonephritis.
Souqiyyeh MZ; Shaheen FA; Alsuwaida A; Alghonaim M; Alwakeel J; Mosa D; Akhtar F; Rahman E; Husain M; Roujouleh H; Siddiqi N; Bukhari I; Sadaqa N; Mushtaque F; Awn NM; Shariya F; Alfi A; Amin M; Ahmad M; Rowaie FA; Almueilo S; Kechrid MC; Karkar A
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):47-55. PubMed ID: 25579715
[TBL] [Abstract][Full Text] [Related]
18. Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis in a young female: a case study.
Singh PP; Krishna A; Sharma A; Kumar O
Ultrastruct Pathol; 2020 Nov; 44(4-6):501-504. PubMed ID: 32657244
[TBL] [Abstract][Full Text] [Related]
19. Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients.
Javaugue V; Karras A; Glowacki F; McGregor B; Lacombe C; Goujon JM; Ragot S; Aucouturier P; Touchard G; Bridoux F
Am J Kidney Dis; 2013 Oct; 62(4):679-90. PubMed ID: 23759297
[TBL] [Abstract][Full Text] [Related]
20. Fibrillary Glomerulonephritis, DNAJB9, and the Unfolded Protein Response.
Andeen NK; Kung VL; Robertson J; Gurley SB; Avasare RS; Sitaraman S
Glomerular Dis; 2022; 2(4):164-175. PubMed ID: 36817290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
